Filter
326
Text search:
adverse
drug
reactions
Featured
Recommendations
38
New Publications
69
Language
Document type
No document type
207
Guidelines
58
Studies & Reports
33
Manuals
10
Strategic & Response Plan
6
Fact sheets
5
Training Material
3
Brochures
2
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
21
South Africa
13
Western and Central Europe
13
Kenya
12
Malawi
8
Global
8
Tanzania
7
Nigeria
6
Ethiopia
6
Ghana
6
Uganda
6
Rwanda
6
Eastern Europe
6
Latin America and the Carribbean
4
Africa
4
Sierra Leone
3
Zimbabwe
3
Philippines
3
Nepal
3
Cambodia
3
Bangladesh
3
USA
2
South Sudan
2
Zambia
2
Syria
2
Namibia
2
Botswana
2
Asia
2
Liberia
1
Congo, Democratic Republic of
1
Cameroon
1
Iraq
1
Germany
1
Lebanon
1
Benin
1
Argentina
1
Eswatini/ Swaziland
1
Ukraine
1
Colombia
1
Myanmar / Burma
1
Sri Lanka
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Laos
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
109
Clinical Guidelines
51
Public Health
16
Women & Child Health
9
Pharmacy & Technologies
6
Capacity Building
5
Key Resources
4
Toolboxes
TB
54
Mental Health
34
Pharmacy
25
HIV
24
NTDs
17
AMR
15
COVID-19
12
Caregiver
7
Ebola & Marburg
6
Refugee
6
Conflict
4
Natural Hazards
4
NCDs
4
Polio
3
Rapid Response
3
Specific Hazards
2
Planetary Health
2
Disability
1
Cholera
1
Zika
1
Global Health Education
1
Malaria
1
2.0 Rapid Response
1
This report outlines the Ministry of Health’s National Health Research Agenda in which it identifies research priorities in health. It will be implemented in the same time frame as the Health Sector Strategic Plain 2012-2018. The Ministry of Health being the implementing agency of this document, i
...
Empfehlungen zur Diagnostik und Therapie nichttuberkulöser Mykobakteriosen des Deutschen Zentralkomitees zur Bekämpfung der Tuberkulose (DZK) und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP).
Schönfeld N et al. Recommendations of the German Central Committee… Pneumolo
...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Towards universal access
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim
...
TB in India 2017
recommended
Revised National TB Control Programme. Annual Status Report
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and
...
8–18 December 2015
Treating the Patient with Tuberculosis
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202
...